Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer

Breast Cancer Research and Treatment

Volumn 128, Issue 1, 2011, Pages 119-126

  Jacobs, Michael A ^a,b   Ouwerkerk, Ronald ^a,c   Wolff, Antonio C ^a,b   Gabrielson, Edward ^a,b   Warzecha, Hind ^a,b   Jeter, Stacie ^a,b   Bluemke, David A ^a,d   Wahl, Richard ^a,b   Stearns, Vered ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Breast; Cancer; Magnetic resonance imaging; PET; PET CT; Response; Sodium 23Na MRI

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE F 18; GADODIAMIDE; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; SODIUM; SODIUM 23;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG MONITORING; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; SODIUM MAGNETIC RESONANCE IMAGING; STANDARDIZED UPTAKE VALUE; TISSUE LEVEL; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG MONITORING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SODIUM ISOTOPES; TAXOIDS; TREATMENT OUTCOME;

EID: 79959275493     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1442-1     Document Type: Article

References (37)

1. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA Cancer J Clin 60 5 277 300 20610543 10.3322/caac.20073
2. AC Wolff D Berry LA Carey M Colleoni M Dowsett M Ellis JE Garber D Mankoff S Paik L Pusztai, et al. 2008 Research issues affecting preoperative systemic therapy for operable breast cancer J Clin Oncol 26 5 806 813 18258990 10.1200/JCO.2007.15.2983 (Pubitemid 351264394)
3. CD Lehman C Gatsonis CK Kuhl RE Hendrick ED Pisano L Hanna S Peacock SF Smazal DD Maki TB Julian, et al. 2007 MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer N Engl J Med 356 13 1295 1303 17392300 10.1056/NEJMoa065447 1:CAS:528:DC%2BD2sXjsFGht70%3D (Pubitemid 46513295)
4. RH El Khouli MA Jacobs DA Bluemke 2008 Magnetic resonance imaging of the breast Semin Roentgenol 43 4 265 281 18774031 10.1053/j.ro.2008.07.002
5. SC Partridge JE Gibbs Y Lu LJ Esserman D Tripathy DS Wolverton HS Rugo ES Hwang CA Ewing NM Hylton 2005 MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival AJR Am J Roentgenol 184 6 1774 1781 15908529 (Pubitemid 40770147)
6. DJ Manton A Chaturvedi A Hubbard MJ Lind M Lowry A Maraveyas MD Pickles DJ Tozer LW Turnbull 2006 Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy Br J Cancer 94 3 427 435 16465174 10.1038/sj.bjc.6602948 1:CAS:528:DC%2BD28XhtFGqs7Y%3D (Pubitemid 43237566)
7. HJ Yu JH Chen RS Mehta O Nalcioglu MY Su 2007 MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy J Magn Reson Imaging 26 3 615 623 17729334 10.1002/jmri.21060 (Pubitemid 350194583)
8. HM Baek JH Chen K Nie HJ Yu S Bahri RS Mehta O Nalcioglu MY Su 2009 Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy Radiology 251 3 653 662 19276320 10.1148/radiol.2512080553
9. 23Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer Acad Radiol 17 12 1477 1485 20863721 10.1016/j.acra.2010.07.009
10. RL Wahl 1998 Positron emission tomography (PET): an update on applications in breast cancer Breast Dis 10 3-4 165 175 15687572 1:STN:280:DC%2BD2M%2FlvVWhsg%3D%3D (Pubitemid 28470211)
11. SJ Kim SK Kim ES Lee J Ro S Kang 2004 Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy Ann Oncol 15 9 1352 1357 15319241 10.1093/annonc/mdh345 (Pubitemid 39295023)
12. G Kelloff JM Hoffman B Johnson HI Scher BA Siegel EY Cheng BD Cheson J O'Shaughnessy KZ Guyton DA Mankoff, et al. 2005 Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development Clin Cancer Res 11 8 2785 2808 15837727 10.1158/1078-0432.CCR-04-2626 1:CAS:528: DC%2BD2MXjtlejsbY%3D (Pubitemid 40525178)
13. M Tatsumi C Cohade KA Mourtzikos EK Fishman RL Wahl 2006 Initial experience with FDG-PET/CT in the evaluation of breast cancer Eur J Nucl Med Mol Imaging 33 3 254 262 16258765 10.1007/s00259-005-1835-7
14. X Chen MO Moore CD Lehman DA Mankoff TJ Lawton S Peacock EK Schubert RB Livingston 2004 Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy Acad Radiol 11 10 1115 1124 15530804 10.1016/j.acra.2004.07.007 (Pubitemid 39458085)
15. A Iagaru R Masamed S Keesara PS Conti 2007 Breast MRI and 18F FDG PET/CT in the management of breast cancer Ann Nucl Med 21 1 33 38 17373334 10.1007/BF03033997 (Pubitemid 46280147)
16. A Berriolo-Riedinger C Touzery JM Riedinger M Toubeau B Coudert L Arnould C Boichot A Cochet P Fumoleau F Brunotte 2007 [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy Eur J Nucl Med Mol Imaging 34 12 1915 1924 17579854 10.1007/s00259-007-0459-5 1:CAS:528:DC%2BD2sXhtlyiurzL (Pubitemid 350212117)
17. Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(suppl 1):122S-150S
18. L Moy F Ponzo ME Noz GQ Maguire Jr AD Murphy-Walcott AE Deans MT Kitazono L Travascio EL Kramer 2007 Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets J Nucl Med 48 4 528 537 17401088 10.2967/jnumed.106.036780 (Pubitemid 47571406)
19. R Ouwerkerk MA Jacobs KJ Macura AC Wolff V Stearns SD Mezban NF Khouri DA Bluemke PA Bottomley 2007 Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive (23)Na MRI Breast Cancer Res Treat 106 2 151 160 17260093 10.1007/s10549-006-9485-4 1:CAS:528:DC%2BD2sXht1CgtL7N (Pubitemid 350045009)
20. FE Boada JS Gillen GX Shen SY Chang KR Thulborn 1997 Fast three dimensional sodium imaging Magn Reson Med 37 5 706 715 9126944 10.1002/mrm.1910370512 1:STN:280:DyaK2s3nt1Squw%3D%3D (Pubitemid 27187810)
21. MA Jacobs RA Knight JP Windham ZG Zhang H Soltanian-Zadeh AV Goussev DJ Peck M Chopp 1999 Identification of cerebral ischemic lesions in rat using eigenimage filtered magnetic resonance imaging Brain Res 837 1-2 83 94 10433991 10.1016/S0006-8993(99)01582-6 1:CAS:528:DyaK1MXlslCkt70%3D (Pubitemid 29369220)
22. RH El Khouli KJ Macura MA Jacobs T Khalil I Kamel A Dwyer DA Bluemke 2009 Dynamic contrast enhanced magnetic resonance imaging of the breast: quantitative method for kinetic curve type assessment Am J Roentgenol 196 4 W295 W300 10.2214/AJR.09.2483
23. P Therasse EA Eisenhauer J Verweij 2006 RECIST revisited: a review of validation studies on tumour assessment Eur J Cancer 42 8 1031 1039 16616487 10.1016/j.ejca.2006.01.026 1:STN:280:DC%2BD283nt1antQ%3D%3D
24. EA Eisenhauer P Therasse J Bogaerts LH Schwartz D Sargent R Ford J Dancey S Arbuck S Gwyther M Mooney, et al. 2009 New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2 228 19097774 10.1016/j.ejca.2008.10.026 1:STN:280:DC%2BD1M%2Fgs12rug%3D%3D
25. JA Thie 2004 Understanding the standardized uptake value, its methods, and implications for usage J Nucl Med 45 9 1431 1434 15347707 (Pubitemid 47618494)
26. L Kenny RC Coombes DM Vigushin A Al-Nahhas S Shousha EO Aboagye 2007 Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F] fluorothymidine positron emission tomography Eur J Nucl Med Mol Imaging 34 9 1339 1347 17333178 10.1007/s00259-007-0379-4 (Pubitemid 47312585)
27. GM McDermott A Welch RT Staff FJ Gilbert L Schweiger SI Semple TA Smith AW Hutcheon ID Miller IC Smith, et al. 2007 Monitoring primary breast cancer throughout chemotherapy using FDG-PET Breast Cancer Res Treat 102 1 75 84 16897427 10.1007/s10549-006-9316-7 1:CAS:528:DC%2BD2sXhslCltrg%3D (Pubitemid 46294965)
28. CC Jaffe 2008 Response assessment in clinical trials: implications for sarcoma clinical trial design Oncologist 13 suppl 2 14 18 18434633 10.1634/theoncologist.13-S2-14
29. AD Van den Abbeele 2008 The lessons of GIST-PET and PET/CT: a new paradigm for imaging Oncologist 13 suppl 2 8 13 18434632 10.1634/theoncologist. 13-S2-8
30. U Sharma KK Danishad V Seenu NR Jagannathan 2009 Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy NMR Biomed 22 1 104 113 18384182 10.1002/nbm.1245
31. KK Danishad U Sharma RG Sah V Seenu R Parshad NR Jagannathan 2010 Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI) NMR Biomed 23 3 233 241 20175134 1:CAS:528:DC%2BC3cXlsFSkt7Y%3D
32. RH Ei Khouli MA Jacobs SD Mezban P Huang IR Kamel KJ Macura DA Bluemke 2010 Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging Radiology 256 1 64 73 20574085 10.1148/radiol.10091367
33. N Avril M Menzel J Dose M Schelling W Weber F Janicke W Nathrath M Schwaiger 2001 Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis J Nucl Med 42 1 9 16 11197987 1:CAS:528:DC%2BD3MXhtF2nsLc%3D (Pubitemid 32104770)
34. G MacGrogan L Mauriac M Durand F Bonichon M Trojani I de Mascarel JM Coindre 1996 Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi Br J Cancer 74 9 1458 1465 8912545 10.1038/bjc.1996.565 1:CAS:528:DyaK28XntVOis7s%3D (Pubitemid 26370740)
35. R Ouwerkerk PA Bottomley M Solaiyappan AE Spooner GF Tomaselli KC Wu RG Weiss 2008 Tissue sodium concentration in myocardial infarction in humans: a quantitative 23Na MR imaging study Radiology 248 1 88 96 18566171 10.1148/radiol.2481071027
36. MA Jacobs R Ouwerkerk I Kamel PA Bottomley DA Bluemke HS Kim 2009 Proton, diffusion-weighted imaging, and sodium ((23)Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study J Magn Reson Imaging 29 3 649 656 19243047 10.1002/jmri.21677
37. EA Mellon DT Pilkinton CM Clark MA Elliott WR Witschey 2nd A Borthakur R Reddy 2009 Sodium MR imaging detection of mild Alzheimer disease: preliminary study AJNR Am J Neuroradiol 30 5 978 984 19213826 10.3174/ajnr.A1495 1:STN:280:DC%2BD1MzjvVKrtQ%3D%3D